ARDT on NYSE

Ardent Health Services

American healthcare company

Ardent Health, Inc., formerly known as Behavioral Healthcare Corporation is a for-profit healthcare company based in Brentwood, Tennessee, United States.³ It was founded by Charles A. Elcan.¹ Its shares trade on NYSE under the symbol ARDT.¹ Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1993Founded¹

Compare with Surgery Partners, Community Health Systems or Universal Health Services, or pick any stock.

TickerARDT on NYSE¹
IndustryServices-General Medical & Surgical Hospitals, NEC¹
HeadquartersNashville¹
Websitewww.ardenthealth.com
Legal formcorporation¹
Incorporated inDE⁴
Business address340 Seven Springs Way, Suite 100, Brentwood, Tn 37027⁴
Filer categoryAccelerated filer⁴

See how the biggest companies compare on our leaderboards

Ardent Health, Inc., formerly known as Behavioral Healthcare Corporation is a for-profit healthcare company based in Brentwood, Tennessee, United States.³

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

2.1%Net margin⁷

6.0%Revenue growth, 2025⁷

10.5%Return on equity⁷

0.84×Debt to equity⁷

Where the money goes

Where each dollar of revenue went, fiscal 2025

Other costs

Other costs97¢$6.1B
Income tax1¢$56.2M
Profit2¢$135.8M

Out of $6.3B in revenue.⁷

Where each dollar of operating cash went, fiscal 2025

Kept or used elsewhere

Kept or used elsewhere100¢$470.5M

Out of $470.5M of cash from operations.⁷

Financial statements

Revenue⁸⁷$6.3B in 2025+23% since 2022

Net income⁸⁷$135.8M in 2025−28% since 2022

Every line of the income statement as filed: the last 3 fiscal years, latest first.⁷

Period ending	2025-12-31	2024-12-31	2023-12-31
Total revenue	$6.3B	$6.0B	$5.4B
Salaries and benefits	$2.7B	$2.5B	$2.4B
Professional fees	$1.2B	$1.1B	$980.3M
Supplies	$1.1B	$1.0B	$993.4M
Other operating expenses	$647.3M	$496.2M	$451.7M
Government stimulus income	$0	$0	-$8.5M
Interest expense	$55.2M	$65.6M	$74.3M
Depreciation and amortization	$155.7M	$146.3M	$140.8M
Loss on extinguishment and modification of debt	$7.3M	$3.4M	$0
Other non-operating gains	-$23.3M	-$26.3M	-$1.6M
Total operating expenses	$6.0B	$5.6B	$5.3B
Income before income taxes	$286.4M	$363.1M	$151.6M
Income tax expense	$56.2M	$63.4M	$22.6M
Net income	$230.1M	$299.7M	$129.0M
Net income attributable to noncontrolling interests	$94.3M	$89.4M	$75.1M
Net income attributable to Ardent Health, Inc.	$135.8M	$210.3M	$53.9M
Net income per common share, basic (in USD per share)	$0.96	$1.59	$0.43
Net income per common share, diluted (in USD per share)	$0.96	$1.58	$0.43
Weighted average number of common shares, basic (in shares)	140.8M shares	132.4M shares	126.1M shares
Weighted average number of common shares, diluted (in shares)	141.5M shares	132.7M shares	126.1M shares

Total assets⁸⁷$5.3B in 2025+12% since 2023

Total liabilities⁸⁷$3.6B in 2025−1% since 2023

Shareholders’ equity⁸⁷$1.3B in 2025+32% since 2021

Cash⁸⁷$709.6M in 2025−1% since 2021

Long-term debt⁸⁷$1.1B in 2025−8% since 2023

Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.⁷

Period ending	2025-12-31	2024-12-31	2024-07-31	2023-12-31	2022-12-31
Cash and cash equivalents	$709.6M	$556.8M
Accounts receivable	$686.1M	$743.0M
Inventories	$118.6M	$115.1M
Prepaid expenses	$112.6M	$113.7M
Other current assets	$431.9M	$304.1M
Total current assets	$2.1B	$1.8B
Property and equipment, net	$935.8M	$861.9M
Goodwill	$879.5M	$852.1M		$844.7M
Other intangible assets	$89.3M	$76.9M
Deferred income taxes	$6.9M	$12.3M
Other assets	$111.7M	$143.0M
Total assets	$5.3B	$5.0B
Current installments of long-term debt	$23.4M	$9.2M
Accounts payable	$457.9M	$401.2M
Accrued salaries and benefits	$296.3M	$295.1M
Other accrued expenses and liabilities	$268.9M	$239.8M
Total current liabilities	$1.0B	$945.4M
Long-term debt, less current installments	$1.1B	$1.1B
Long-term operating lease liability	$1.2B
Self-insured liabilities	$241.1M	$227.0M
Other long-term liabilities	$76.6M	$34.7M
Total liabilities	$3.6B	$3.4B
Redeemable noncontrolling interests	-$1.2M	$1.2M		$7.3M	$10.8M
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; no shares issued and outstanding	$0	$0
Common stock, par value $0.01 per share; 750,000,000 shares authorized; 142,864,171 and 142,747,818 shares issued and outstanding as of December 31, 2025 and 2024, respectively	$1.4M	$1.4M
Additional paid-in capital	$788.5M	$754.4M
Accumulated other comprehensive (loss) income	-$3.6M	$9.7M
Retained earnings	$501.6M	$365.8M
Equity attributable to Ardent Health, Inc.	$1.3B	$1.1B
Noncontrolling interests	$398.3M	$389.8M
Total equity	$1.7B	$1.5B		$1.1B	$1.0B
Total liabilities and equity	$5.3B	$5.0B
Preferred stock, par value (in USD per share)	$0.01	$0.01	$0.01
Preferred stock, shares authorized (in shares)	50.0M shares	50.0M shares	50.0M shares
Preferred stock, shares issued (in shares)	0 shares	0 shares
Preferred stock, shares outstanding (in shares)	0 shares	0 shares
Common stock, par value (in USD per share)	$0.01	$0.01	$0.01
Common stock, shares authorized (in shares)	750.0M shares	750.0M shares	750.0M shares
Common stock, shares, issued (in shares)	142.9M shares	142.7M shares
Common stock, shares, outstanding (in shares)	142.9M shares	142.7M shares

Period ending	2025-12-31	2024-12-31	2024-07-31	2023-12-31	2022-12-31
Cash and cash equivalents	$709.6M	$556.8M
Accounts receivable	$686.1M	$743.0M
Inventories	$118.6M	$115.1M
Prepaid expenses	$112.6M	$113.7M
Other current assets	$431.9M	$304.1M
Total current assets	$2.1B	$1.8B
Property and equipment, net	$935.8M	$861.9M
Goodwill	$879.5M	$852.1M		$844.7M
Other intangible assets	$89.3M	$76.9M
Deferred income taxes	$6.9M	$12.3M
Other assets	$111.7M	$143.0M
Total assets	$5.3B	$5.0B
Current installments of long-term debt	$23.4M	$9.2M
Accounts payable	$457.9M	$401.2M
Accrued salaries and benefits	$296.3M	$295.1M
Other accrued expenses and liabilities	$268.9M	$239.8M
Total current liabilities	$1.0B	$945.4M
Long-term debt, less current installments	$1.1B	$1.1B
Long-term operating lease liability	$1.2B
Self-insured liabilities	$241.1M	$227.0M
Other long-term liabilities	$76.6M	$34.7M
Total liabilities	$3.6B	$3.4B
Redeemable noncontrolling interests	-$1.2M	$1.2M		$7.3M	$10.8M
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; no shares issued and outstanding	$0	$0
Common stock, par value $0.01 per share; 750,000,000 shares authorized; 142,864,171 and 142,747,818 shares issued and outstanding as of December 31, 2025 and 2024, respectively	$1.4M	$1.4M
Additional paid-in capital	$788.5M	$754.4M
Accumulated other comprehensive (loss) income	-$3.6M	$9.7M
Retained earnings	$501.6M	$365.8M
Equity attributable to Ardent Health, Inc.	$1.3B	$1.1B
Noncontrolling interests	$398.3M	$389.8M
Total equity	$1.7B	$1.5B		$1.1B	$1.0B
Total liabilities and equity	$5.3B	$5.0B
Preferred stock, par value (in USD per share)	$0.01	$0.01	$0.01
Preferred stock, shares authorized (in shares)	50.0M shares	50.0M shares	50.0M shares
Preferred stock, shares issued (in shares)	0 shares	0 shares
Preferred stock, shares outstanding (in shares)	0 shares	0 shares
Common stock, par value (in USD per share)	$0.01	$0.01	$0.01
Common stock, shares authorized (in shares)	750.0M shares	750.0M shares	750.0M shares
Common stock, shares, issued (in shares)	142.9M shares	142.7M shares
Common stock, shares, outstanding (in shares)	142.9M shares	142.7M shares

Cash from operations⁸⁷$470.5M in 2025

Dividends paid⁸$0 in 2024

Every line of the cash flow as filed: the last 3 fiscal years, latest first.⁷

Period ending	2025-12-31	2024-12-31	2023-12-31
Net income	$230.1M	$299.7M	$129.0M
Depreciation and amortization	$155.7M	$146.3M	$140.8M
Loss on extinguishment and modification of debt	$515.0K	$2.2M	$0
Amortization of deferred financing costs and debt discounts	$4.4M	$5.5M	$5.0M
Deferred income taxes	$43.6M	$24.0M	$4.0M
Equity-based compensation	$39.3M	$18.0M	$904.0K
(Income) loss from non-consolidated affiliates	-$1.0M	$5.8M	-$1.7M
Accounts receivable	$59.2M	$40.0M	-$181.1M
Inventories	-$3.1M	-$9.4M	$1.7M
Prepaid expenses and other current assets	-$122.1M	-$136.0M	-$36.6M
Accounts payable and other accrued expenses and liabilities	$62.1M	-$103.9M	$136.8M
Accrued salaries and benefits	$686.0K	$27.5M	$22.9M
Net cash provided by operating activities	$470.5M	$315.0M	$221.7M
Investment in acquisitions, net of cash acquired	-$2.5M	-$35.5M	$0
Purchases of property and equipment	-$211.9M	-$187.5M	-$137.4M
Other	$179.0K	-$1.7M	-$575.0K
Net cash used in investing activities	-$214.2M	-$220.5M	-$138.0M
Proceeds from initial public offering, net of underwriting discounts and commissions	$0	$208.7M	$0
Proceeds from revolving line of credit	$0	$0	$125.0M
Proceeds from insurance financing arrangements	$15.6M	$10.8M	$24.7M
Proceeds from long-term debt	$0	$3.6M	$6.6M
Payments of principal on revolving line of credit	$0	$0	-$125.0M
Payments of principal on insurance financing arrangements	-$15.0M	-$10.4M	-$22.9M
Payments of principal on long-term debt	-$8.0M	-$108.4M	-$13.6M
Debt issuance costs	-$2.6M	-$2.5M	$0
Payments of initial public offering costs	$0	-$9.5M	$0
Distributions to noncontrolling interests	-$88.2M	-$72.9M	-$63.9M
Redemption of equity attributable to noncontrolling interests	$0	$0	-$26.0M
Other	-$5.2M	$5.2M	-$7.2M
Net cash (used in) provided by financing activities	-$103.5M	$24.6M	-$102.3M
Net increase (decrease) in cash and cash equivalents	$152.8M	$119.2M	-$18.5M
Non-cash purchases of property and equipment	$16.4M	$9.3M	$16.4M
Offering costs not yet paid	$0	$330.0K	$0
Income tax payments, net	$36.5M	$41.6M	$19.4M

Compare Ardent Health Services with another company

Corporate structure

Ardent Health Services sits at the top of its group. 125 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Ardent Health Services

CHAI TRUST CO LLC Filed SC 13G on Ardent Health Services, latest Nov 14, 2024
Pure Health Capital Americas 1 SPV RSC LTD Filed SC 13G on Ardent Health Services, latest Nov 14, 2024
Ventas, Inc. Filed SC 13G on Ardent Health Services, latest Nov 14, 2024

Ardent Health Services Nashville
- 22 Walnut Crescent, LLC Subsidiary · Delaware, United States
- 4 George, LLC Subsidiary · Delaware, United States
- Access Direct-A Preferred Provider Network, Inc. Subsidiary · Texas, United States
- AHP Health Partners, Inc. Subsidiary · Delaware, United States
- AHS Acquisitions, LLC Subsidiary · Delaware, United States
- AHS Albuquerque Holdings, LLC Subsidiary · New Mexico, United States
- AHS BSA, LLC Subsidiary · Delaware, United States
- AHS Claremore Regional Hospital, LLC Subsidiary · Delaware, United States
- AHS Cushing Hospital, LLC Subsidiary · Delaware, United States
- AHS East Texas Health System, LLC Subsidiary · Texas, United States
- AHS Henryetta Hospital, LLC Subsidiary · Delaware, United States
- AHS Hillcrest Healthcare System, LLC Subsidiary · Delaware, United States
- AHS Hillcrest Medical Center, LLC Subsidiary · Delaware, United States
- AHS Innovation Enterprises, LLC Subsidiary · Delaware, United States
- AHS Kansas Health System, Inc. Subsidiary · Delaware, United States
- AHS Management Company, Inc. Subsidiary · Tennessee, United States
- AHS Management Services of Oklahoma, LLC Subsidiary · Delaware, United States
- AHS Newco 17, LLC Subsidiary · Delaware, United States
- AHS Newco 18, LLC Subsidiary · Delaware, United States
- AHS Nurse Staffing Solutions, LLC Subsidiary · New Mexico, United States
- AHS Oklahoma Heart, LLC Subsidiary · Delaware, United States
- AHS Oklahoma Physician Group, LLC Subsidiary · Delaware, United States
- AHS Oklahoma, LLC Subsidiary · Delaware, United States
- AHS Operations Holdings, LLC Subsidiary · Delaware, United States
- AHS Physician Partners, LLC Subsidiary · Delaware, United States
- and 99 more

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Ardent Health Services reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, before depreciation	$1.9B⁸ Dec 31, 2024	$1.7B⁸ Dec 31, 2023	+8.0%
Accumulated depreciation	$989.5M⁸ Dec 31, 2024	$902.5M⁸ Dec 31, 2023	+9.6%
Property and equipment, net	$861.9M⁸ Dec 31, 2024	$811.1M⁸ Dec 31, 2023	+6.3%
Finance-lease assets	$53.9M⁷ Dec 31, 2025	$51.2M⁷ Dec 31, 2024	+5.3%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$709.6M⁷ Dec 31, 2025	$556.8M⁷ Dec 31, 2024	+27.4%

Intangibles and goodwill

Item	Latest	A year before	Change
Goodwill	$879.5M⁷ Dec 31, 2025	$852.1M⁷ Dec 31, 2024	+3.2%
Finite-lived intangibles, gross	$13.2M⁷ Dec 31, 2025
Finite-lived intangibles, net	$12.4M⁷ Dec 31, 2025

Inventory

Item	Latest	A year before	Change
Inventory, total	$118.6M⁷ Dec 31, 2025	$115.1M⁷ Dec 31, 2024	+3.0%

Properties, in its own words

The disclosure required under this Item is included in "Item 1. Business—Our Properties and Facilities" and "Item 1. Business—Our Platform" of this Annual Report.

Item 2 of the 10-K filed Mar 16, 2026.¹¹

The story

Founded by Charles A. Elcan in 1993.¹

The Behavioral Healthcare Corporation was founded in 1993 by Edward Stack. Until 2001, it was a privately held company owned by Kindred Healthcare and Welsh Carson Anderson & Stowe and several individual investors and focused owning and operating behavioral health facilities. It currently owns and operates hospitals in Tulsa, Oklahoma, Albuquerque, New Mexico, Amarillo, Texas, Pocatello, Idaho, Topeka, Kansas, 2 in New Jersey and, as of March 1, 2018, UTHET in Tyler, Texas.

By 2001, the private equity firm Welsh, Carson, Anderson & Stowe became majority shareholders and changed the name of the company.

The company sold its behavioral health operations to Psychiatric Solutions, Inc. in 2005.

In 2015, Ventas acquired the company for $1.75b through a traditional sale-leaseback transaction where Ventas remained the owner of essentially all of Ardent's real property interests while a joint venture between Equity Group Investments, Ventas and several members of management acquired its hospital operations.

In February 2018, Ardent Health Services acquired the East Texas Medical Center (ETMC) hospital system, and created the Tyler Regional Hospital, LLC, purchased the name-rights of the University of Texas Health Sciences Brand, and created a Doing-Business-As name of "UT Health Tyler." Tyler Regional Hospital, LLC continues operating under the UT Health Brand but is not currently under the University of Texas umbrella of administration. Currently, the University of Texas system owns a 30% share in the hospital while Ardent Health owns a 70% share.

In February 2020, Ardent Health Services president and CEO David T. Vandewater announced his plans to retire from the company. He remained president and CEO until a successor was named.

In August 2020, Ardent Health Services appointed Martin J. Bonick as president and CEO. Today the company has 26,000 employees, 30 hospitals, and over 200 sites of care in six states.

From Wikipedia’s article on Ardent Health, shared under CC BY-SA 4.0.⁵

Leadership

Who has led Ardent Health Services, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

Alfred Lumsdaine2024–now

Chief operating officer

Dave Caspers2025–now

1995200020052010201520202025

FounderCharles A. Elcan¹
Chief executive officerDave Caspers Jul 2, 2026 to now¹²
Chief executive officerMartin Bonick Jul 17, 2024 to Jul 2, 2026¹³
PresidentDave Caspers Jul 2, 2026 to now¹²
PresidentDavid Schultz Apr 2, 2025 to Jul 2, 2026¹⁴
PresidentEthan Chernin Jul 17, 2024 to Apr 2, 2025¹⁵
PresidentMartin Bonick Jul 17, 2024 to Apr 2, 2025¹³
Chief financial officerAlfred Lumsdaine Jul 17, 2024 to now¹⁶
Chief operating officerDave Caspers Apr 2, 2025 to now¹⁷

Board members and other officers (14)

SVP & Chief Accounting OfficerDavid Raynor Byers Jul 17, 2024 to now¹⁸
OfficerDavid Schultz Jul 17, 2024 to Sep 27, 2024¹⁹
Executive VP, GC and SecretaryStephen C. Petrovich Jul 17, 2024 to now²⁰
Board memberDave Caspers Jul 2, 2026 to now¹²
Board memberRobert Demichiei Apr 4, 2025 to now²¹
Board memberEdmondo Robinson Jul 17, 2024 to now²²
Board memberEllen Havdala Jul 17, 2024 to now²³
Board memberMark R. Sotir Jul 17, 2024 to now²⁴
Board memberMartin Bonick Jul 17, 2024 to now¹³
Board memberPeter C. B. Bynoe Jul 17, 2024 to now²⁵
Board memberPeter J. Bulgarelli Jul 17, 2024 to now²⁶
Board memberRahul Sen Jul 17, 2024 to now²⁷
Board memberSuzanne Campion Jul 17, 2024 to now²⁸
Board memberWilliam M. Goodyear Jul 17, 2024 to now²⁹

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

22 Walnut Crescent, LLC Delaware⁶
4 George, LLC Delaware⁶
AHP Health Partners, Inc. Delaware⁶
AHS Acquisitions, LLC Delaware⁶
AHS Albuquerque Holdings, LLC New Mexico⁶
AHS BSA, LLC Delaware⁶
AHS Claremore Regional Hospital, LLC Delaware⁶
AHS Cushing Hospital, LLC Delaware⁶
AHS East Texas Health System, LLC Texas⁶
AHS Henryetta Hospital, LLC Delaware⁶
AHS Hillcrest Healthcare System, LLC Delaware⁶
AHS Hillcrest Medical Center, LLC Delaware⁶
AHS Innovation Enterprises, LLC Delaware⁶
AHS Kansas Health System, Inc. Delaware⁶
AHS Management Company, Inc. Tennessee⁶
AHS Management Services of Oklahoma, LLC Delaware⁶
AHS Newco 17, LLC Delaware⁶
AHS Newco 18, LLC Delaware⁶
AHS Nurse Staffing Solutions, LLC New Mexico⁶
AHS Oklahoma Heart, LLC Delaware⁶
AHS Oklahoma Physician Group, LLC Delaware⁶
AHS Oklahoma, LLC Delaware⁶
AHS Operations Holdings, LLC Delaware⁶
AHS PSO, LLC Delaware⁶

All 124 listed subsidiaries

AHS Physician Partners, LLC Delaware⁶
AHS Pryor Hospital, LLC Delaware⁶
AHS Southcrest Hospital, LLC Delaware⁶
AHS Strategic Ventures, LLC Delaware⁶
AHS Texas, LLC Delaware⁶
AHS Tulsa Holdings, LLC Delaware⁶
Access Direct-A Preferred Provider Network, Inc. Texas⁶
Amarillo Surgery And Endoscopy, LP Texas⁶
Ardent Legacy Holdings, LLC Delaware⁶
Athens Hospital, LLC Delaware⁶
BSA Amarillo Diagnostic Clinic, Inc. Texas⁶
BSA Amarillo Surgery and Endoscopy GP, LLC Texas⁶
BSA Cardiac ASC, LLC Texas⁶
BSA Cardiac Care Group, Inc. Texas⁶
BSA Harrington Physicians, Inc. Texas⁶
BSA Health System Holdings, LLC Texas⁶
BSA Health System Management, LLC Texas⁶
BSA Health System of Amarillo, LLC Texas⁶
BSA Hospital, LLC Texas⁶
BSA Physicians Group, Inc. Texas⁶
Bailey Medical Center, LLC Delaware⁶
Bay County Sacred Heart Leasing Co, LLC Florida⁶
Belton Imaging Center, LLC Delaware⁶
Carthage Hospital, LLC Delaware⁶
Centralized Credentialing Services, Inc. Texas⁶
Cyberknife, Ltd. Texas⁶
ETMC EMS Texas⁶
ETMC Physician Group, Inc. Texas⁶
East Texas Air One, LLC Delaware⁶
East Texas Health System, LLC Texas⁶
East Texas Holdings, LLC Delaware⁶
East Texas UC Acquisition, LLC Delaware⁶
East Texas Urgent Care Holdings, LLC Delaware⁶
East Texas Urgent Care, LLC Delaware⁶
FMC Services, LLC Texas⁶
Freedom Urgent Care, PLLC Texas⁶
HH/Killeen Health System, LLC Delaware⁶
Henderson Hospital, LLC Delaware⁶
Hillcrest Urgent Care, LLC Delaware⁶
Jacksonville Hospital, LLC Delaware⁶
LHP Bay County, LLC Delaware⁶
LHP HH/Killeen, LLC Delaware⁶
LHP Hospital Group, Inc. Delaware⁶
LHP IT Services, LLC Delaware⁶
LHP Management Services, LLC Delaware⁶
LHP Montclair LLC New Jersey⁶
LHP Operations Co., LLC Delaware⁶
LHP Pascack Valley, LLC New Jersey⁶
LHP Pocatello, LLC Delaware⁶
LHP Sherman/Grayson, LLC Texas⁶
LHP Southwest Connecticut, LLC Delaware⁶
LHP Texas MD Services, Inc. Texas⁶
LHP Texas Physicians, LLC Texas⁶
LHS Services, Inc. New Mexico⁶
LHS Valencia County, LLC New Mexico⁶
Lovelace Health System, LLC New Mexico⁶
Lovelace IP, LLC New Mexico⁶
Lovelace UNM Rehabilitation Hospital, LLC New Mexico⁶
Lovelace Urgent Care, LLC New Mexico⁶
MPV New Jersey MD Services, P.C. New Jersey⁶
Montclair Health Services, LLC New Jersey⁶
Montclair Health System, LLC New Jersey⁶
Montclair Hospital, LLC Delaware⁶
New Mexico Heart Institute, LLC New Mexico⁶
Open Air Imaging Center, LLP Texas⁶
PHS Ambulatory Services, LLC Delaware⁶
PHS MD #1, LLC Delaware⁶
PHS MD #2, LLC Delaware⁶
PHS/MVH JV, LLC Delaware⁶
Pascack Valley Health Services, LLC New Jersey⁶
Pascack Valley Health System, LLC New Jersey⁶
Pascack Valley Hospital, LLC New Jersey⁶
Patient Quality Alliance VCO, LLC Idaho⁶
Patient Quality Alliance, LLC Delaware⁶
Physicians Surgical Hospitals, LLC Texas⁶
Physicians Surgical Real Estate, LLC Texas⁶
Pittsburg Hospital, LLC Delaware⁶
Pocatello Health Services, LLC Delaware⁶
Pocatello Health System, LLC Delaware⁶
Pocatello Hospital, LLC Delaware⁶
Portneuf ASC, LLC Delaware⁶
Quitman Hospital, LLC Delaware⁶
Rehabilitation Hospital, LLC Delaware⁶
Rose City Benefits, Inc. Texas⁶
Rose City Brokerage, Inc. Texas⁶
Rose City Care Management, Inc. Texas⁶
Seton Urgent Care, LLC Delaware⁶
Sherman/Grayson Health System, LLC Texas⁶
Southwest Medical Associates, LLC New Mexico⁶
Specialty Hospital, LLC Delaware⁶
Tallgrass Surgical Center, LLC Kansas⁶
Topeka Health System, LLC Delaware⁶
Topeka Holdings, LLC Delaware⁶
Topeka Hospital, LLC Delaware⁶
Topeka Physician Group, LLC Delaware⁶
Topeka Urgent Care, LLC Delaware⁶
Tulsa Spine And Specialty Hospital, LLC Oklahoma⁶
Tyler Regional Hospital, LLC Delaware⁶
UK St. Francis Urgent Care, LLC Delaware⁶
UT East Texas Urgent Care Centers, PLLC Texas⁶

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

Ardent Health Partners, Inc.Apr 12, 2024 to May 23, 2025⁴
Ardent Health Partners, LLCOct 26, 2018 to Jul 16, 2024⁴

Timeline

Sep 4, 20268-K Other events³⁰
Aug 4, 20268-K Results of operations³¹
Jul 2, 2026New chief executive Dave Caspers becomes CEO¹²
Jun 30, 20268-K Executive or director change³²
Jun 2, 20268-K Executive or director change; Regulation FD disclosure³³
May 26, 20268-K Shareholder vote³⁴
May 5, 20268-K Results of operations³⁵
Mar 27, 20268-K Executive or director change³⁶
Mar 4, 20268-K Results of operations³⁷
Nov 18, 20258-K Regulation FD disclosure; Other events³⁸
Nov 12, 20258-K Results of operations³⁹
Sep 23, 20258-K Entered a material agreement; New debt or obligation⁴⁰
Aug 5, 20258-K Results of operations⁴¹
Jul 17, 2024New chief executive Martin Bonick becomes CEO¹³
1993Founded Founded¹

Calendar

Coming up

Nov 4, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.52 a share, on Nov 12, 2025.⁴²

When it reported results

Aug 4, 2026Reported quarterly or annual results³¹
May 5, 2026Reported quarterly or annual results³⁵
Mar 4, 2026Reported quarterly or annual results³⁷
Nov 12, 2025Reported quarterly or annual results³⁹
Aug 5, 2025Reported quarterly or annual results⁴¹
May 6, 2025Reported quarterly or annual results⁴³
Feb 26, 2025Reported quarterly or annual results⁴⁴
Jan 13, 2025Reported quarterly or annual results⁴⁵

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

168 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 21 major events, 89 insider forms, 3 large holders, 46 other. The latest 20:

Sep 29, 20264 EDGAR
Sep 29, 20264 EDGAR
Sep 29, 20264 EDGAR
Sep 4, 20268-K EDGAR
Aug 27, 2026144 EDGAR
Aug 25, 2026144 EDGAR
Aug 20, 2026144 EDGAR
Aug 18, 2026144 EDGAR
Aug 10, 202610-Q EDGAR
Aug 4, 20268-K EDGAR
Jul 2, 20264 EDGAR
Jun 30, 20268-K EDGAR
Jun 8, 20264 EDGAR
Jun 8, 20264 EDGAR
Jun 2, 20268-K EDGAR
May 26, 20268-K EDGAR
May 6, 202610-Q EDGAR
May 5, 20268-K EDGAR
Apr 8, 2026ARS EDGAR
Apr 8, 2026DEFA14A EDGAR

The 168 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

3 open-market trades by officers, directors and large owners since October 2021: 3 buys and 0 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Jun 5, 2026	DeMichiei RobertDirector	Buy	11,260	$8.73	$98.3K	Form 4
Jun 5, 2026	LUMSDAINE ALFREDChief Financial Officer	Buy	10,000	$8.81	$88.1K	Form 4
Nov 8, 2024	Webb Robert ThomasDirector	Buy	20,000	$16.98	$339.6K	Form 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

CHAI TRUST CO LLCSC 13G, 1 filing Nov 14, 2024⁴⁶
Pure Health Capital Americas 1 SPV RSC LTDSC 13G, 1 filing Nov 14, 2024⁴⁷
Ventas, Inc.SC 13G, 1 filing Nov 14, 2024⁴⁸

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

Year	Executive	Age	Salary	Total pay
2025	Marty BonickPresident and Chief Executive Officer	52	$1.1M	$6.1M⁴⁹
2025	Alfred LumsdaineChief Financial Officer	60	$650.2K	$2.7M⁴⁹
2025	David CaspersChief Operating Officer	55	$511.5K	$2.4M⁴⁹
2025	David SchultzFormer President, Hospital Operations		$389.9K	$2.1M⁴⁹
2025	Ethan CherninFormer President, Health Services		$612.5K	$1.5M⁴⁹
2025	Stephen C. PetrovichExecutive Vice President and General Counsel	59	$547.1K	$1.4M⁴⁹
2024	Marty BonickPresident and Chief Executive Officer	52	$1.1M	$6.9M⁴⁹
2024	Alfred LumsdaineChief Financial Officer	60	$622.6K	$3.4M⁴⁹
2024	David SchultzFormer President, Hospital Operations		$652.1K	$3.0M⁴⁹
2024	Stephen C. PetrovichExecutive Vice President and General Counsel	59	$531.1K	$2.0M⁴⁹
2024	Ethan CherninFormer President, Health Services		$343.9K	$1.5M⁴⁹
2023	Marty BonickPresident and Chief Executive Officer	52	$988.6K	$2.2M⁴⁹
2023	Alfred LumsdaineChief Financial Officer	60	$594.3K	$1.3M⁴⁹
2023	Stephen C. PetrovichExecutive Vice President and General Counsel	59	$508.6K	$958.2K⁴⁹
2023	David SchultzFormer President, Hospital Operations		$342.9K	$725.6K⁴⁹

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
Chai Trust Co LLC	77,246,499	$760.1M	52.3%	No change
Ventas, Inc.	9,342,501	$91.9M	100.0%	No change
BlackRock, Inc.	2,176,348	$21.4M	0.0%	+418,133
Ameriprise Financial Inc	2,110,599	$20.8M	0.0%	+333,873
Goldentree Asset Management LP	1,580,423	$15.5M	0.9%	−722,690
Aqr Capital Management LLC	1,447,810	$14.2M	0.0%	+505,457
CastleKnight Management LP	1,076,967	$10.6M	0.4%	No change
Vanguard Capital Management LLC	963,833	$9.5M	0.0%	−44,605
Bridgeway Capital Management, LLC	841,126	$8.3M	0.1%	−89,542
Geode Capital Management, LLC	620,947	$6.1M	0.0%	+59,504
Algert Global LLC	597,745	$5.9M	0.1%	+554,345
State Street Corp	566,205	$5.6M	0.0%	−19,853
First Trust Advisors LP	562,278	$5.5M	0.0%	+83,483
Empowered Funds, LLC	551,293	$5.4M	0.0%	+15,458
SageView Advisory Group, LLC	480,447	$4.7M	0.2%	−160,149
Hotchkis & Wiley Capital Management LLC	444,896	$4.4M	0.0%	+2,300
UBS Group AG	442,619	$4.4M	0.0%	−8,061
Bank Of America Corp /de/	390,241	$3.8M	0.0%	+29,203
Wedge Capital Management L L P/nc	327,242	$3.2M	0.1%	+222,447
Morgan Stanley	315,960	$3.1M	0.0%	+23,929
American Century Companies Inc	309,359	$3.0M	0.0%	+254,167
Goldman Sachs Group Inc	304,449	$3.0M	0.0%	+85,438
Jane Street Group, LLC	300,343	$3.0M	0.0%	+106,322
Jpmorgan Chase & Co	242,329	$2.4M	0.0%	+73,721
Bank of New York Mellon Corp	241,587	$2.4M	0.0%	+535

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Ardent Health Services is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARArdent Health, Inc.²
CIK0001756655
Employer ID (EIN)61-1764793¹¹
Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company¹¹
Incorporated inDelaware¹¹
Fiscal year endsDecember 31²
Industry code (SIC)8062 Services-General Medical & Surgical Hospitals, NEC²
SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance²
Business address340 Seven Springs Way, Suite 100, Brentwood, TN 37027²
Phone6152963000²
Shares outstanding141,045,907 as of Aug 7, 2026¹⁰
Public float$324.3M as of Jun 30, 2025¹¹
AuditorErnst & Young LLP, Nashville, Tennessee, United States of America PCAOB ID 42; it also attests to the company’s internal control over financial reporting¹¹
On EDGAR sinceOct 26, 2018²
Filings173 in all: 4 (70), 8-K (21), 3 (19), 10-Q (7), CORRESP (6), UPLOAD (6), S-1/A (5), 144 (4)²
All 27 form types
DRSLTR (4), DRS (3), SC 13G (3), SEC STAFF LETTER (3), 10-K (2), ARS (2), DEF 14A (2), DEFA14A (2), DRS/A (2), EFFECT (2), S-1 (2), 424B2 (1), 424B4 (1), 8-A12B (1), ARS/A (1), CERT (1), RW (1), S-3 (1), S-8 (1)
Latest filingsAnnual report (10-K) Mar 16, 2026
Quarterly report (10-Q) Aug 10, 2026
Proxy statement (DEF 14A) Apr 8, 2026
Latest 8-K (8-K) Sep 4, 2026

Securities registered for trading

Class	Symbol	Exchange
Common Stock, $0.01 par value per share	ARDT	New York Stock Exchange

From the cover page of the 10-K filed Mar 16, 2026 (Section 12(b) of the Exchange Act).¹¹

Risk factors and legal proceedings

The risks Ardent Health Services names in Item 1A of its 10-K filed Mar 16, 2026: 54 risks under these headings, as written.¹¹

Risks Related to Our Business and Industry
Changes in government healthcare programs, including Medicare and Medicaid, could have an adverse effect on our revenues and business.
If reimbursement rates paid by commercial payors are reduced or we experience increased reimbursement denials or payment delays by commercial payors, if we are unable to retain and negotiate favorable contracts with private third party payors, if insured individuals move to health plans with greater coverage exclusions or restrictions or narrower networks, or if our volume of uninsured or underinsured patients increases, our revenues may decline.
Our business may be adversely impacted by changes in healthcare laws, regulations, policies and government programs.
Our business could be negatively affected by security threats, catastrophic events and other disruptions affecting our, our service providers’ or our JV partners’ information technology and related systems, which have adversely affected, and could in the future adversely affect, our relationships with patients and business partners and subject us to legal claims and liabilities, reputational harm and business disruption and adversely affect our financial condition.
Our hospitals, outpatient centers and other healthcare businesses operate in competitive environments, and competition in our markets may adversely affect patient volumes and other aspects of our business.
Our performance depends on our ability to recruit and retain quality physicians.
Our financial performance could be adversely affected by competition for staffing, the shortage of experienced nurses and other healthcare professionals, labor union activity and factors related to our employment of physicians.
Changes to physician utilization practices and treatment methodologies and other factors outside our control that impact demand for medical services may reduce our revenues and ability to grow profitably.
Third party payor controls designed to reduce costs and other payor practices intended to decrease inpatient services, surgical procedure volumes or reimbursement for services rendered may reduce our revenues.
Industry trends towards value-based purchasing and care coordination among healthcare providers may present us with operational, financial and competitive challenges.
We depend on key personnel, and losing one or more of our senior management team or local management personnel could have a material adverse effect on our business.

The other 43 risks

We may not be able to successfully complete acquisitions or strategic JVs on acceptable terms, which may slow our growth rate.
We may fail to realize all of the anticipated benefits of our past and any future acquisitions, or those benefits may take longer to realize than expected. We may also encounter significant difficulties in integrating these acquired businesses into our operations.
We may be subject to liabilities because of claims brought against our hospitals, physician practices, outpatient facilities or other business operations or against healthcare providers that provide services at our facilities.
We conduct a significant portion of our operations through JVs, which may expose us to certain risks and uncertainties, including risks as a result of our lack of sole decision-making authority. In addition, we may be required under certain circumstances to purchase our JV partners’ equity interests, which could adversely affect our liquidity and financial condition.
The failure to obtain our medical supplies and drugs at favorable prices or in sufficient volumes could cause our operating results to decline.
We are subject to a variety of operational, legal and financial risks associated with outsourcing functions to third parties.
Our facilities are heavily concentrated in Texas and Oklahoma, which makes us sensitive to regulatory, economic and competitive conditions and changes in those states.
General economic and business conditions, both nationally and in the regions in which we operate, including the impact of challenging macroeconomic conditions and inflationary pressures, current geopolitical instability, and impacts from the imposition of, or changes in, tariffs, as well as the potential impact of federal government shut downs or other uncertain political, financial, credit and capital conditions, have affected, and may continue to impact, our business, financial condition and results of operations.
Our hospitals and other healthcare facilities may be negatively impacted by severe weather, climate change, and other factors beyond our control, which could restrict patient access to care or cause one or more of our facilities to close temporarily or permanently.
We face certain risks related to the Ventas Master Lease, pursuant to which we lease ten of our hospitals and the associated Relative Rights Agreement.
Our principal equity holders’ interests may conflict with yours.
Our significant level of indebtedness, and the ability to refinance such indebtedness on acceptable terms, could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, and prevent us from meeting our obligations under our debt instruments.
The agreements that govern our existing indebtedness impose significant operating and financial restrictions on us and our subsidiaries, which may prevent us from capitalizing on business opportunities, and we may be unable to refinance such indebtedness on acceptable terms.
Despite our current level of indebtedness, we may be able to incur substantially more debt and enter into other transactions which could further exacerbate the risks to our financial condition described above.
Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly. We are also exposed to interest rate volatility, which could result in higher-than market interest rates and may have a material adverse effect on our business, financial condition, results of operations and prospects.
A deterioration of public health conditions associated with a future pandemic, epidemic or outbreak of an infectious disease in the markets in which we operate or that otherwise affects our facilities could adversely impact our business.
The estimates of market opportunity and forecasts of market growth included in this report may prove to be inaccurate, and even if our addressable markets achieve the forecasted growth, our business could fail to grow at similar rates.
If certain large employers in the local markets where our hospitals operate cease or substantially reduce their business operations, a disproportionately large number of community residents who depend on our hospitals and other healthcare facilities for their care may lose insurance coverage or decide to move elsewhere, which could adversely affect our business and results of operations.
Our cash and cash equivalents could be adversely affected if the financial institutions in which we hold our cash and cash equivalents fail.
Risks Related to Regulation
If we fail to comply with extensive laws and government regulations, we could suffer penalties or be required to make significant changes to our operations.
We may be the subject of government investigations, claims, audits, whistleblower and other litigation and payor audits.
We are required to treat patients with emergency medical conditions regardless of ability to pay.
Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, results of operations and financial condition.
We may not be able to construct, acquire, sell, renovate or expand healthcare facilities. In addition, the acquisition of minority interests, including of ten percent (10%) or more of the outstanding equity of certain of our hospital facilities, may be subject to prior approval by certain state regulators where we operate, and the failure to obtain any such required approval may result in the imposition of significant fines on us and/or the loss of licensure, which could have an adverse effect on our results of operations.
Failure to comply with federal and state laws and regulations relating to Medicare and Medicaid enrollment, permit, licensing and accreditation requirements, or the expansion of existing or the enactment of new laws or regulation relating to permit, licensing and accreditation requirements, could result in fines, penalties and other adverse action, the loss of Medicare and Medicaid enrollment, licenses, permits and accreditations and adversely affect our business and our financial condition.
There are significant legal and regulatory restrictions on our hospitals that have physician owners.
Tax matters, including disagreements with taxing authorities and imposition of new taxes, could impact our results of operations and financial condition.
We incur substantial costs as a result of operating as a public company and our management is required to devote substantial time to new compliance initiatives and corporate governance practices of which we have limited experience.
If we fail to maintain proper and effective internal control over financial reporting, our ability to produce accurate and timely financial statements could be impaired and investors’ views of us could be harmed.
Risks Related to Technology
Healthcare technology initiatives, particularly those related to sharing patient data and interoperability, may adversely affect our operations.
If we do not continually enhance our hospitals with the most recent technological advances in diagnostic and surgical equipment or obtain reimbursement from third party payors for the cost of such new technologies, our business and results of operations may be adversely affected.
Our efforts to implement new technologies, including AI and machine learning, could have an adverse impact on our business, financial condition, results of operations, or growth plans.
Risks Related to Ownership of our Common Stock
Our stock price could be volatile, and, as a result, our stockholders may not be able to resell their shares at or above the price paid for them.
We are currently, and may in the future be, subject to securities litigation, which is expensive and could divert management’s time and attention from our business, and could have a material adverse effect on our results of operations, financial condition, prospects and stock price.
If our operating and financial performance in any given period does not meet the guidance that we provide to the public, the price of our common stock may decline.
We are a “controlled company” within the meaning of the rules of the NYSE and, as a result we rely on, exemptions from certain corporate governance requirements; you will not have the same protections afforded to stockholders of companies that are subject to all such requirements.
Certain of our directors have relationships with our controlling stockholder, EGI-AM, and other affiliated entities of Equity Group Investments (“EGI”), which may cause conflicts of interest with respect to our business.
Our certificate of incorporation contains a provision renouncing our interest and expectancy in certain corporate opportunities.
Some provisions of Delaware law and our governing documents could discourage a takeover that stockholders may consider favorable.
Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees.
Future sales, or the perception of future sales, of our common stock may depress the price of our common stock.
If securities or industry analysts do not publish research or publish misleading or unfavorable research about our business, our share price and trading volume may decline.
We do not intend to pay cash dividends for the foreseeable future.

Legal proceedings

Because we provide healthcare services in a highly regulated industry, we have been, are, and expect to continue to be, party to various lawsuits and regulatory investigations from time to time. In addition to the information set forth in this section, refer to the "Litigation and Regulatory Matters" section of Note 13, Commitments and Contingencies, in the notes to the consolidated financial statements contained elsewhere in this Annual Report.

Securities Litigation

On January 7, 2026, a purported stockholder filed a putative securities class action against the Company and certain current officers in the lawsuit styled Postiwala v. Ardent Health, Inc., et al., Case No. 3:26-cv-00022, which is pending in the United States District Court for the Middle District of Tennessee, Nashville Division. The complaint is brought on behalf of a putative class consisting of all persons (other than defendants) who purchased our securities between July 18, 2024 and November 12, 2025, and alleges that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder based on allegedly false and misleading statements and omissions. Specifically, the complaint alleges that we incorrectly accounted for and reported on certain accounts receivable and certain insurance reserves during 2024 and 2025 which caused our stock price to be inflated. The complaint seeks unspecified monetary damages, recovery of fees and costs, and other relief that the court may find appropriate.

We intend to vigorously defend the claims made; however, currently no assessment can be made as to the likely outcome. At this time, we are not able to reasonably estimate the amount or range of the ultimate liability, if any, in connection with this case.

The opening of Item 3, Legal Proceedings.¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataArdent Health Services on Wikidata
2
SEC EDGARArdent Health Services filings on SEC EDGAR
3
WikipediaArdent Health Services on Wikipedia
4
SEC EDGARArdent Health Services filings on SEC EDGAR
5
WikipediaArdent Health Services on Wikipedia (revision used)
6
SEC EDGARArdent Health Services annual report, Exhibit 21 (subsidiaries)
7
SEC EDGARArdent Health Services 10-K for fiscal 2025
8
SEC EDGARArdent Health Services 10-K for fiscal 2022
9
SEC EDGARArdent Health Services 10-Q for fiscal 2026
10
SEC EDGARArdent Health Services 10-Q for fiscal 2026
11
SEC EDGARArdent Health Services 10-K filed Mar 16, 2026: Item 2, Properties
12
SEC EDGARDave Caspers, Chief executive officer
13
SEC EDGARMartin Bonick, Chief executive officer
14
SEC EDGARDavid Schultz, President
15
SEC EDGAREthan Chernin, President
16
SEC EDGARAlfred Lumsdaine, Chief financial officer
17
SEC EDGARDave Caspers, Chief operating officer
18
SEC EDGARDavid Raynor Byers, SVP & Chief Accounting Officer
19
SEC EDGARDavid Schultz, Officer
20
SEC EDGARStephen C. Petrovich, Executive VP, GC and Secretary
21
SEC EDGARRobert Demichiei, Board member
22
SEC EDGAREdmondo Robinson, Board member
23
SEC EDGAREllen Havdala, Board member
24
SEC EDGARMark R. Sotir, Board member
25
SEC EDGARPeter C. B. Bynoe, Board member
26
SEC EDGARPeter J. Bulgarelli, Board member
27
SEC EDGARRahul Sen, Board member
28
SEC EDGARSuzanne Campion, Board member
29
SEC EDGARWilliam M. Goodyear, Board member
30
SEC EDGAROther events
31
SEC EDGARResults of operations
32
SEC EDGARExecutive or director change
33
SEC EDGARExecutive or director change; Regulation FD disclosure
34
SEC EDGARShareholder vote
35
SEC EDGARResults of operations
36
SEC EDGARExecutive or director change
37
SEC EDGARResults of operations
38
SEC EDGARRegulation FD disclosure; Other events
39
SEC EDGARResults of operations
40
SEC EDGAREntered a material agreement; New debt or obligation
41
SEC EDGARResults of operations
42
NasdaqNasdaq calendar
43
SEC EDGARArdent Health Services 8-K, Item 2.02 (results of operations)
44
SEC EDGARArdent Health Services 8-K, Item 2.02 (results of operations)
45
SEC EDGARArdent Health Services 8-K, Item 2.02 (results of operations)
46
SEC EDGARCHAI TRUST CO LLC SC 13G on Ardent Health Services
47
SEC EDGARPure Health Capital Americas 1 SPV RSC LTD SC 13G on Ardent Health Services
48
SEC EDGARVentas, Inc. SC 13G on Ardent Health Services
49
SEC EDGARArdent Health Services proxy statement (DEF 14A), 2025 pay